Clinical trial
DHA and X-Linked Retinitis Pigmentosa
NCT00100230 · Retina Foundation of the Southwest, Other · Completed
Key facts
| NCT number | NCT00100230 |
|---|---|
| Title | DHA and X-Linked Retinitis Pigmentosa |
| Official title | Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa |
| Lead sponsor | Retina Foundation of the Southwest, Other |
| Collaborators | Foundation Fighting Blindness DSM Nutritional Products, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa, X-linked Genetic Diseases |
| Intervention type | Drug |
| Interventions | docosahexaenoic acid OR corn/soy oil placebo |
| Enrollment | 78 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2012 |
| Completion | Aug 1, 2014 |
| First posted | Dec 28, 2004 |
| Last update posted | Mar 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: